SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-038510
Filing Date
2013-05-08
Accepted
2013-05-08 08:02:25
Documents
3
Period of Report
2013-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-11707_18k.htm 8-K 21136
2 EX-99.1 a13-11707_1ex99d1.htm EX-99.1 118505
3 GRAPHIC g117071mmi001.jpg GRAPHIC 3049
  Complete submission text file 0001104659-13-038510.txt   145306
Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 13822333
SIC: 2834 Pharmaceutical Preparations